Glimaday P 1mg/500mg/15mg Tablet ER
By Glimaday-P
Rx
10 Tablet ER in a Strip

Composition
Glimepiride(1mg) + Metformin(500mg) + Pioglitazone(15mg)

Manufacturer - Wockhardt Ltd
Wockhardt Towers, Bandra Kurla Complex, Bandra (East), Mumbai 400051, Maharashtra, India

Expires on or after
October, 2025

liver
When using Glimaday P 1mg/500mg/15mg Tablet ER, it is important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment when taking Glimaday P 1mg/500mg/15mg Tablet ER, so it's best to consult your doctor before use. However, individuals with severe liver disease are advised not to use Glimaday P 1mg/500mg/15mg Tablet ER. It's crucial to follow your healthcare provider's guidance closely for your safety.

kidney
Glimaday P 1mg/500mg/15mg Tablet ER should be used carefully in patients with kidney issues. Adjusting the dose may be necessary. Refrain from using it in severe kidney problems. Monitor kidney function regularly when on this medication.

alcohol
Do not drink alcohol while taking Glimaday P 1mg/500mg/15mg Tablet ER.

driving
When taking Glimaday P 1mg/500mg/15mg Tablet ER, be cautious when driving. If you experience low or high blood sugar symptoms, refrain from driving as it could affect your ability to focus and react effectively.

pregnancy
Glimaday P 1mg/500mg/15mg Tablet ER could be harmful during pregnancy due to limited human studies and observed risks in animal studies. Consult your doctor for guidance as they will assess the benefits and potential risks before prescribing this medication to you.

breastfeeding
Caution Glimaday P 1mg/500mg/15mg Tablet ER is likely unsafe while breastfeeding. Limited data indicates the drug can pass into breastmilk and potentially harm the infant.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹102
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024